Novartis AG - Liabilities and Stockholders Equity
Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Liabilities-and-Stockholders-Equity" stands at 107.29 Billion United States Dollars as of 09/30/2025, the highest value since 12/31/2023.
As of the end of Novartis AG's third quarter, the item "Liabilities and Stockholders Equity" stands at 107.29 Billion USD. This represents an increase of 2.77 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.64 percent compared to the value the year prior.
The 1 year change in percent is 3.64.
The 3 year change in percent is -9.43.
The 5 year change in percent is -17.27.
The 10 year change in percent is -19.29.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +13.73%.
The Serie's change in percent from it's maximum value, on 12/31/2018, to it's latest available value, on 09/30/2025, is -26.29%.
Liabilities and Stockholders Equity for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Liabilities and Stockholders Equity | 905,699,262,464.00 |
 | Johnson & Johnson - Liabilities and Stockholders Equity | 486,508,953,600.00 |
 | AbbVie Inc - Liabilities and Stockholders Equity | 399,570,305,024.00 |
 | Roche Holding AG - Liabilities and Stockholders Equity | 317,433,206,677.55 |
 | AstraZeneca PLC - Liabilities and Stockholders Equity | 280,205,508,085.11 |